MARKET

ICUCW

ICUCW

SeaStar Medical
NASDAQ
0.0196
-0.0004
-2.00%
Closed 16:52 05/13 EDT
OPEN
0.0197
PREV CLOSE
0.0196
HIGH
0.0197
LOW
0.0196
VOLUME
4.70K
TURNOVER
0
52 WEEK HIGH
0.0750
52 WEEK LOW
0.0084
MARKET CAP
--
P/E (TTM)
-0.0033
1D
5D
1M
3M
1Y
5Y
1D
Seastar Medical targets about $2M 2026 QUELIMMUNE revenue while aiming to finish NEUTRALIZE-AKI enrollment by end of 2026
Seeking Alpha · 12h ago
SeaStar Medical Q1 revenue rises on QUELIMMUNE growth
Reuters · 15h ago
SEASTAR MEDICAL REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES
Reuters · 15h ago
Weekly Report: what happened at ICUCW last week (0504-0508)?
Weekly Report · 3d ago
SEASTAR MEDICAL HOLDING CORP - PROSPECTUS RELATES TO RESALE, FROM TIME TO TIME, OF UP TO 2 MLN SHARES OF OUR COMMON STOCK BY SELLING STOCKHOLDER
Reuters · 6d ago
SeaStar Medical to report first-quarter financial results after market close May 13
PUBT · 05/06 12:20
Weekly Report: what happened at ICUCW last week (0427-0501)?
Weekly Report · 05/04 09:11
SeaStar Medical securities class action dismissed with prejudice, court order shows
PUBT · 04/28 20:17
More
About ICUCW
SeaStar Medical Holding Corporation is a commercial-stage medical technology company. The Company is focused on developing extracorporeal therapies to reduce the consequences of hyperinflammation on vital organs. The Company's technologies rely on science to provide life-saving solutions to critically ill patients. The Company develops and commercializes cell-directed extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company uses its Selective Cytopheretic Device (SCD) technology platform to clinically validate several acute organ injury indications, including kidneys and lungs. Its investigational SCD is an extracorporeal synthetic membrane device designed to integrate into existing continuous renal replacement therapy (CRRT) systems that are commonly installed in hospitals throughout the United States.

Webull offers SeaStar Medical Holding Corp stock information, including NASDAQ: ICUCW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICUCW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ICUCW stock methods without spending real money on the virtual paper trading platform.